The distance function effect on k-nearest neighbor classification for medical datasets.
Li-Yu Hu, Min-Wei Huang, Shih-Wen Ke...
https://pubmed.ncbi.nlm.nih.gov/27547678Actively Recruiting
Led by Hanger Institute for Clinical Research and Education, LLC · Updated on 2026-02-05
100
Participants Needed
1
Research Sites
N/A
Total Duration
H
Hanger Institute for Clinical Research and Education, LLC
Lead Sponsor
U
University of Washington
Collaborating Sponsor
Researchers are evaluating whether microprocessor-controlled prosthetic knees (MPKs), which have built-in computers, improve health outcomes related to falls in adults who use above-knee prostheses. This study focuses on users classified as limited community ambulators (Medicare Functional Level K2) and aims to find out if MPKs reduce fall-related health issues, increase mobility and walking speed, and enhance quality of life compared to non-microprocessor-controlled prosthetic knees (nMPKs). The study is a 12-month randomized control trial where participants who recently received an nMPK are assigned to either continue using their nMPK or switch to an MPK. Those receiving the MPK will get either a stance-and-swing MPK (Ottobock C-Leg 4) or a stance-only MPK (Ottobock Kenevo), based on their walking speed measured by a 2-minute walk test. Participants will undergo education and training specific to their prosthetic knee and will wear the assigned knee for the full study duration. Participants will be assessed at baseline and at 1, 3, 6, 9, and 12 months, with primary assessments at baseline and 12 months. Researchers will collect data on fall-related self-efficacy, anxiety, avoidance behaviors, interference, and the number of falls every two weeks. Mobility, walking speed, endurance, quality of life, and prosthesis wear and activity hours will also be measured. Fall and near-fall events, including injuries and treatments, will be closely monitored throughout the study.
CONDITIONS
Effects of Microprocessor-controlled Prosthetic Knees on Fall-related Health Outcomes in Limited Community Ambulators
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 day
Eligible participants are consented, randomized, and complete baseline assessments including performance tests and self-report surveys related to fall-related health and mobility.
1 baseline visit (in-person)
Duration - Between baseline and 1-month follow-up
Participants randomized to the intervention group receive a microprocessor-controlled prosthetic knee (MPK) based on walking speed, while control group participants continue using their prescribed non-microprocessor knee (nMPK). All participants receive 1 to 4 training sessions to facilitate prosthesis use.
1 to 4 training sessions (in-person)
Duration - 12 months
Participants wear their assigned prosthetic knee and complete follow-up assessments of fall-related health outcomes and mobility at 1, 3, 6, 9, and 12 months after baseline, including standardized tests and self-report surveys.
5 follow-up visits (in-person) at 1, 3, 6, 9, and 12 months
Duration - 12 months
Participants report the number of falls and near-fall events every two weeks throughout the 12-month participation period, including details on injury and prosthesis use during the event.
Biweekly check-ins (remote or in-person) every 2 weeks
Total: 1 location
1
Hanger Inc.
Austin, Texas, United States, 78758
Actively Recruiting
S
Shane R. Wurdeman, PhD
B
Bretta L. Fylstra, PhD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Li-Yu Hu, Min-Wei Huang, Shih-Wen Ke...
https://pubmed.ncbi.nlm.nih.gov/27547678Dale Berry
https://pubmed.ncbi.nlm.nih.gov/16517347Jeehyoung Kim, Wonshik Shin
https://pubmed.ncbi.nlm.nih.gov/24605197Jimmy Efird
https://pubmed.ncbi.nlm.nih.gov/21318011Valerie J Eberly, Sara J Mulroy, JoAnne K Gronley...
https://pubmed.ncbi.nlm.nih.gov/24135259Brian J Hafner, Douglas G Smith
https://pubmed.ncbi.nlm.nih.gov/19675993Brian J Hafner, Laura L Willingham, Noelle C Buell...
https://pubmed.ncbi.nlm.nih.gov/17270519F Jepson, D Datta, I Harris...
https://pubmed.ncbi.nlm.nih.gov/18330807Jason T Kahle, M Jason Highsmith, Sandra L Hubbard
https://pubmed.ncbi.nlm.nih.gov/18566922Tim Pauley, Michael Devlin, Kathleen Heslin
https://pubmed.ncbi.nlm.nih.gov/16715022